Amyris Exceeds Previous Debt Reduction Goal of $75 Million – $86 Million In Debt Retired
May 22, 2017 08:30 ET
|
Amyris
EMERYVILLE, Calif., May 22, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced it has already exceeded the debt reduction goal the company stated...
Amyris Reports 164% Product Revenue Growth over Prior Year & Continued Strong Outlook
May 15, 2017 16:21 ET
|
Amyris
Q1 2017 revenues of $13.0 million, up 47% over $8.8 million for Q1 2016Q1 2017 product sales of $8.3 million, up 164% over $3.1 million for Q1 2016 with Biossance sales also at a record level powered...
Amyris Announces Closing Of First Tranche Of Up To $95 Million In Equity Financing And Conversion Of Over $55 Million Of Debt To Equity
May 11, 2017 15:38 ET
|
Amyris
EMERYVILLE, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced the closing of the first tranche of up to $95 million in planned...
Amyris On-Track To Double Revenue For Vitamin E Partnership With Nenter & Announces Exclusive Vitamin A License With Royal DSM
May 10, 2017 08:30 ET
|
Amyris
EMERYVILLE, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it expects revenue related to its Vitamin E partnership with...
Amyris to Host & Videocast 1st Annual Biotech Summit and Investor Day on Tuesday, May 16, 2017
May 09, 2017 08:30 ET
|
Amyris
EMERYVILLE, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) today announced that it will host its 1st Annual Biotech Summit on Tuesday, May 16, 2017 at its headquarters in...
Amyris to Announce First Quarter 2017 Financial Results on Monday, May 15, 2017
May 09, 2017 08:00 ET
|
Amyris
EMERYVILLE, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2017 after market close on Monday, May 15,...
Royal DSM To Make Equity Investment In Amyris With the Purpose of Establishing a Long-Term Relationship
May 08, 2017 08:30 ET
|
Amyris; Royal DSM
HEERLEN, Netherlands and EMERYVILLE, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and Koninklijke DSM N.V. (Royal DSM) (AEX:DSM.AS), the...
Amyris Announces Agreements For Up to $95 Million In Equity Financing And In-Process Initiative To Significantly Reduce Debt
May 08, 2017 08:30 ET
|
Amyris
EMERYVILLE, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced a series of agreements for up to $95 million in equity financing...
Amyris Announces Much Better Than Expected Sales Of Farnesene To Meet Accelerated Demand For Liquid Farnesene Rubber By Global Tire Brands
May 05, 2017 08:00 ET
|
Amyris
EMERYVILLE, Calif., May 05, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that its partner’s success in developing high performance liquid...
Amyris Announces Key Advancements Under DARPA Multi-Year Technology Investment Agreement – Enables Development of Industrial-Scale Fermentation Process For Virtually Any Biological Molecule
May 02, 2017 08:00 ET
|
Amyris
EMERYVILLE, Calif., May 02, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has successfully expanded its world-class expertise in...